EPIFIL: A dynamic model of infection and disease in lymphatic filariasis

American Journal of Tropical Medicine and Hygiene

Volumn 59, Issue 4, 1998, Pages 606-614

  Chan, M S ^a   Srividya, A ^b   Norman, R A ^c   Pani, S P ^b   Ramaiah, K D ^b   Vanamail, P ^b   Michael, E ^a   Das, P K ^b   Bundy, D A P ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b VECTOR CONTROL RESEARCH CENTRE   (India)

^c UNIVERSITY OF STIRLING   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AGE; ARTICLE; DISEASE COURSE; FILARIASIS; HUMAN; HYDROCELE; IMMUNOPATHOLOGY; INDIA; INFECTION CONTROL; LYMPHATIC SYSTEM INFECTION; LYMPHEDEMA; MATHEMATICAL MODEL; PATHOGENESIS; POPULATION DYNAMICS;

NEMATODA;

EID: 0031724302     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.1998.59.606     Document Type: Article

References (48)

1. Michael E, Bundy DAP, Grenfell BT, 1996. Re-assessing the global prevalence and distribution of lymphatic filariasis. Parasitology 112: 409-428.
2. Michael E, Bundy DAP, 1997. Global mapping of lymphatic filariasis. Parasitol Today 13: 472-476.
3. Ottesen EA, 1994. The human filariases: new understandings, new therapeutic strategies. Curr Opin Infect Dis 7: 550-558.
4. Southgate BA, 1984. Recent advances in the epidemiology and control of filarial infections including entomological aspects of transmission. Trans R Soc Trop Med Hyg 78: 19-28.
5. Bundy DAP, Grenfell BT, Rajagopalan PK, 1991. Immunoepidemiology of lymphatic filariasis: the relationship between infection and disease. Immunoparasitol Today (suppl): A71-A75.
6. Grenfell BT, Michael E, 1992. Infection and disease in lymphatic filariasis: an epidemiological approach. Parasitology 104: S81-S90.
7. Michael E, Grenfell BT, Bundy DAR 1994. The association between microfilaraemia and disease in lymphatic filariasis. Proc R Soc Lond B Biol Sci 256: 33-40.
8. Michael E, Meyrowitsch DW, Simonsen PE, 1996. Cost and cost effectiveness of mass diethylcarbamazine chemotherapy for the control of bancroftian filariasis: comparison of four strategies in Tanzania. Trop Med Int Health 1: 414-426.
9. Anderson RM, May, RM, 1992. Infectious Diseases of Humans. Oxford: Oxford University Press.
10. Medley GL, Guyatt HL, Bundy DAP, 1993. A quantitative framework for evaluating the effect of community treatment on the morbidity due to ascariasis. Parasitology 106: 211-221.
11. Chan MS, Guyatt HL, Bundy DAP, Medley GF, 1994. The development and validation of an age structured model for the evaluation of disease control strategies for intestinal helminths. Parasitology 109: 389-396.
12. Plaisier AP, van Oortmarssen GJ, Habbema JDF, Remme J, Alley ES, 1990. ONCHOSIM: a model and computer simulation program for the transmission and control of onchocerciasis. Comp Meth Prog Biomed 31: 43-56.
13. Chan MS, Guyatt HL, Bundy DAP, Booth M, Fulford AJC, Medley GF, 1995. The development of an age structured model for schistosomiasis transmission dynamics and control and its validation for Schistosoma mansoni. Epidemiol Infect 115: 325-344.
14. Muench H, 1959. Catalytic Models in Epidemiology. Cambridge, MA: Harvard University Press.
15. Hayashi S, 1962. A mathematical analysis on the epidemiology of bancroftian and malayan filariasis in Japan. Jpn J Exp Med 32: 13-43.
16. Hairston NG, Jachowski LA, 1968. Analysis of the Wuchereria bancrofti population in the people of American Samoa. Bull World Health Organ 38: 29-59.
17. Vanamail P, Subramanian S, Das PK, Pani SP, Rajagopala PK, Bundy DAP, Grenfell BT, 1989. Estimation of age specific rates of acquisition and loss of Wuchereria bancrofti infection. Trans R Soc Trop Med Hyg 83: 689-693.
18. Srividya A, Pani SP, Rajagopalan PK, Bundy DAP, Grenfell, BT, 1991. The dynamics of infection and disease in Bancroftian filariasis. Trans R Soc Trop Med Hyg 85: 255-259.
19. Chan MS, Guyatt HL, Bundy DAP, Medley GF, 1996. Dynamic models of schistosomiasis morbidity. Am J Trop Med Hyg 55: 52-62.
20. Medley GF, Bundy DAP, 1996. Dynamic modeling of epidemiologic patterns of schistosomiasis morbidity. Am J Trop Med Hyg 55 (suppl): 149-158.
21. Das PK, Manoharan A, Srividya A, Grenfell BT, Bundy DAP, Vanamail P, 1990. Frequency distribution of Wuchereria bancrofti microfilariae in human populations and its relationships with age and sex. Parasitology 101: 429-434.
22. Day KP, Grenfell B, Spark R, Kazura JW, Alpers MP, 1991. Age specific patterns of change in the dynamics of Wuchereria bancrofti infection in Papua New Guinea. Am J Trop Med Hyg 44: 518-527.
23. Ottesen EA, 1992. Infection and disease in lymphatic filariasis: an immunological perspective. Parasitology 104: S71-S79.
24. Woolhouse MEJ, 1992. A theoretical framework for the immunoepidemiology of helminth infection. Parasite Immunol 14: 563-578.
25. Olszewski W, Jamal S, 1994. Skin bacterial factors in progression of filarial lymphodema. Lymphology 27: 148-149.
26. Pani SP, Yuvaraj J, Vanamail P, Dhanda V, Michael E, Grenfell BT, Bundy DAP, 1995. Episodic adenolymphangitis and lymphodema in patients with bancroftian filariasis. Trans R Soc Trop Med Hyg 89: 72-74.
27. Day KP, Gregory WF, Maizels RM, 1991. Age-specific acquisition of immunity to infective larvae in a bancroftian filariasis endemic area of Papua New Guinea. Parasite Immunol 13: 277-290.
28. Grenfell BT, Michael E, Denham DA, 1991. A model for the dynamics of human lymphatic filariasis. Parasitol Today 7: 318-323.
29. Michael E, Grenfell BT, Isham VS, Denham DA, Bundy DAP, 1998. Modelling variability in lymphatic filariasis: macrofilarial dynamics in the Brugia pahangi-cat model. Proc R Soc Lond B Biol Sci 265: 155-165.
30. Amaral F, Dreyer G, Figueredo-Silva J, Noroes J, Cavalcanti A, Samico, SC, Santos A, Coutinho A, 1994. Live adult worms detected by ultrasonography in human bancroftian filariasis. Am J Trop Med Hyg 50: 753-757.
31. Freedman DO, 1998. Immunopathogenesis of human lymphatic filariasis. Parasitol Today 14: 229-234.
32. Addiss DG, Dimock KA, Eberhard ML, Lammie PJ, 1995. Clinical, parasitological and immunologic observations of patients with hydrocele and elephantiasis in an area with endemic lymphatic filariasis. J Infect Dis 171: 755-758.
33. Maizels RM, Sartono E, Kurniawan A, Partono F, Selkirk ME, Yazdanbakhsh M, 1995. T-cell activation and the balance of antibody isotopes in human lymphatic filariasis. Parasitol Today 11: 50-57.
34. WHO, 1992. Lymphatic filariasis: the disease and its control. World Health Organ Tech Rep Ser 821.
35. Lindsey JK, 1996. Parametric Statistical inference. New York: Oxford University Press.
36. Anderson RM, May RM, 1985. Herd immunity to helminth infection and implications for parasite control. Nature 315: 493-496.
37. Rajagopalan PK, Das PK, Subramanian S, Vanamail P, Ramaiah KD, 1989. Bancroftian filariasis in Pondicherry, South India: 1. Pre-control epidemiological observations. Epidemiol Infect 103: 685-692.
38. Pani SP, Balakrishnan N, Srividya A, Bundy DAP, Grenfell BT, 1991. Clinical Epidemiology of Bancroftian filariasis: effect of age and gender. Trans R Soc Trop Med Hyg 85: 260-264.
39. Grenfell BT, Das PK, Rajagopalan PK, Bundy DAP, 1990. Frequency distribution of lymphatic filariasis microfilariae in human populations: population processes and statistical estimation. Parasitology 104: 417-427.
40. Guyatt HL, Bundy DAP, Medley GF, Grenfell BT, 1990. The relationship between the frequency distribution of Ascaris lumbricoides and the prevalence and intensity of infection in human communities. Parasitology 101: 139-143.
41. Meyrowitsch DW, Simonsen PE, Makunde WH, 1995. Bancroftian filariasis: analysis of infection and disease in five endemic communities of north-eastern Tanzania. Ann Trop Med Parasitol 89: 653-663.
42. Maizels RM, Lawrence R, 1991. Immunological tolerance: the key feature in human filariasis? Parasitol Today 7: 271-276.
43. Guyat, HL, Bundy DAP, 1991. Estimating prevalence of community morbidity due to intestinal helminths: prevalence of infection as an indication of the prevalence of disease. Trans R Soc Trop Med Hyg 85: 778-782.
44. Chan MS, Medley GF, Jamison D, Bundy D.A.P, 1994. The evaluation of potential global morbidity atttributable to intestinal nematode infections. Parasitology 109: 373-387.
45. Maizels RM, Bundy DAP, Selkirk ME, Smith DF, Anderson RM, 1993. Immunological modulation and evasion by helminth parasites in human populations. Nature 365: 797-805.
46. Lammie PJ, Hitch WL, Allen EMW, Hightower W, Eberhard ML, 1991. Maternal filarial infection as risk factor for infection in children. Lancet 337: 1005-1006.
47. Kar SK, Mania J, 1993. Filarial hydrocele and its treatment with DEC. Prog Lymphology 14: 364-368.
48. Michael E, Bundy DAP, 1998. Herd immunity to filarial infection is a function of vector biting rate. Proc R Soc Lond B Biol Sci 265: 855-860.